» Authors » Manish Joshi

Manish Joshi

Explore the profile of Manish Joshi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 82
Citations 597
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Goyal M, Menon B, Ospel J, Almekhlafi M, Zerna C, Nogueira R, et al.
J Stroke . 2025 Feb; 27(1):95-101. PMID: 39916458
Background And Purpose: In the ESCAPE-NA1 (Efficacy and Safety of Nerinetide for the Treatment of Acute Ischaemic Stroke) trial, treatment with nerinetide was associated with improved outcomes in patients who...
2.
Smith E, Phillips N, Feldman H, Borrie M, Ganesh A, Henri-Bhargava A, et al.
J Prev Alzheimers Dis . 2025 Feb; 12(3):100068. PMID: 39893139
Lecanemab and donanemab are monoclonal antibody therapies that remove amyloid-beta from the brain. They are the first therapies that alter a fundamental mechanism, amyloid-beta deposition, in Alzheimer disease (AD). To...
3.
Joshi M, Varkey B
Curr Opin Pulm Med . 2025 Jan; 31(2):77-78. PMID: 39878001
No abstract available.
4.
Mishra G, Kumar M, Tripathi S, Joshi M, Kumar S, Saud T, et al.
J Hazard Mater . 2025 Jan; 488():137248. PMID: 39874754
Experiments were conducted in controlled laboratory conditions to determine the size-resolved CCN (Cloud Condensation Nuclei) activity of sub micrometer-sized aerosols containing nuclear fission products (CsI and CsOH) and abundant ambient...
5.
Ospel J, Goyal M, Menon B, Almekhlafi M, Zerna C, Nogueira R, et al.
Stroke . 2024 Dec; 56(1):14-21. PMID: 39648909
Background: In the ESCAPE-NA1 trial (Efficacy and Safety of Nerinetide for the Treatment of Acute Ischemic Stroke), treatment with nerinetide was associated with a smaller infarct volume among patients who...
6.
Joshi M, Joshi A, Bartter T
Curr Opin Pulm Med . 2024 Dec; 31(2):79-88. PMID: 39620702
Purpose Of Review: To present an overview of the impact of climate change upon human respiratory health. Recent Findings: Climate change is directly impacting air quality. Particulate matter clearly increases...
7.
Duchesne S, Collins D, Barlow L, Bartha R, Black S, Chertkow H, et al.
Can J Neurol Sci . 2024 Nov; 1-9. PMID: 39494933
Background: Disease-modifying therapies (DMTs) for Alzheimer's disease (AD) are emerging following successful clinical trials of therapies targeting amyloid beta (Aβ) protofibrils or plaques. Determining patient eligibility and monitoring treatment efficacy...
8.
Kumar A, Joshi M, Singh P, Semwal P, Singh K, Sapra B
Sci Rep . 2024 Oct; 14(1):24720. PMID: 39433815
Humans receive around 50% of natural radiation dose due to Rn (radon), Rn (thoron) and their decay products. Several field campaigns measuring these gases and the decay products in different...
9.
Buwaniwal A, Joshi M, Sharma V, Gupta G, Khan A, Kansal S, et al.
Chemosphere . 2024 Jul; 363:142949. PMID: 39067825
Gravimetry-based direct measurements of mass concentration require offline analysis which is not suited for field campaigns. Hence such campaigns rely on the estimation of mass concentration by indirect methods mostly...
10.
Ahamad T, Nautiyal O, Joshi M, Singh P, Sajwan R, Rana A, et al.
Radiat Prot Dosimetry . 2024 Jul; 200(11-12):1011-1017. PMID: 39016486
Alpha flux radiated from 222Rn, 220Rn and progeny is the primary contributor of natural radioactivity to the inhabitants in the ambient atmosphere. The annual indoor 222Rn and 220Rn concentrations were...